Antiverse

Designing antibodies for difficult targets

Antiverse helps pharmaceutical, biotechnology and research partners develop antibodies against targets such as G-protein coupled receptors and ion channels. Its platform generates candidate designs using specialized biological data, then tests them in engineered cell lines and feeds the laboratory results into further design cycles.

The Cardiff-based company combines computational design with its own laboratory capabilities. It works on partner discovery programs and an internal therapeutic pipeline, optimizing antibodies for both target binding and properties needed for drug development.